The effect of heritability and host genetics on the gut microbiota and metabolic syndrome

Gut

Volumn 66, Issue 6, 2017, Pages 1031-1038

  Lim, Mi Young ^a   You, Hyun Ju ^a   Yoon, Hyo Shin ^a   Kwon, Bomi ^a   Lee, Jae Yoon ^a   Lee, Sunghee ^a   Song, Yun Mi ^b   Lee, Kayoung ^c   Sung, Joohon ^a   Ko, Gwangpyo ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

ENERGY METABOLISM; ENTERIC BACTERIAL MICROFLORA; GENETIC POLYMORPHISMS

Indexed keywords

TRIACYLGLYCEROL; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A5; RNA 16S;

ADULT; AGED; AKKERMANSIA; APOA5 GENE; ARTICLE; BACTERIUM; BIFIDOBACTERIUM; CONTROLLED STUDY; DIZYGOTIC TWINS; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HERITABILITY; HOST; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; METHANOBREVIBACTER; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MONOZYGOTIC TWINS; NONHUMAN; ODORIBACTER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUTTERELLA; TAXON; ALLELE; BACTEROIDETES; BETAPROTEOBACTERIA; DYSBIOSIS; FECES; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; TWINS; VERRUCOMICROBIA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN A-V; BACTEROIDETES; BETAPROTEOBACTERIA; BIFIDOBACTERIUM; DYSBIOSIS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GENE-ENVIRONMENT INTERACTION; GENOTYPE; HUMANS; LACTOBACILLUS; MALE; METABOLIC SYNDROME X; METHANOBREVIBACTER; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, RIBOSOMAL, 16S; VERRUCOMICROBIA; YOUNG ADULT;

EID: 84963958983     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-311326     Document Type: Article

References (55)

1. Wilson PW, DAgostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-72.
2. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629-36.
3. Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: A randomized trial. JAMA 2004;292:1440-6.
4. Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014;2014:943162.
5. Kraja AT, Vaidya D, Pankow JS, et al. A bivariate genome-wide approach to metabolic syndrome STAMPEED consortium. Diabetes 2011;60:1329-39.
6. Samuel BS, Shaito A, Motoike T. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-Acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 2008;105:16767-72.
7. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004;101:15718-23.
8. Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008;57:1470-81.
9. Zupancic ML, Cantarel BL, Liu Z, et al. Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PLoS ONE 2012;7:e43052.
10. Turnbaugh P, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009;457:480-4.
11. Delzenne NM, Neyrinck AM, Bäckhed F, et al. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 2011;7:639-46.
12. Zhang C, Zhang M, Wang S, et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 2009;4:232-41.
13. Benson AK, Kelly SA, Legge R, et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci USA 2010;107:18933-8.
14. Goodrich JK, Waters JL, Poole AC, et al. Human genetics shape the gut microbiome. Cell 2014;159:789-99.
15. Rehman A, Sina C, Gavrilova O, et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011;60:1354-62.
16. Rausch P, Rehman A, Könzel S, et al Colonic mucosa-Associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci USA 2011;108:19030-5.
17. OBrien PJ, Alborn WE, Sloan JH, et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 2005;51:351-9.
18. Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001;294:169-73.
19. Tan A, Sun J, Xia N, et al. A genome-wide association and gene-environment interaction study for serum triglycerides levels in a healthy Chinese male population. Hum Mol Genet 2012;21:1658-64.
20. Hong K-W, Jeong SW, Chung M, et al. Association between expression quantitative trait loci and metabolic traits in two Korean populations. PLoS ONE 2014;9:e114128.
21. Yamada Y, Ichihara S, Kato K, et al. Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people. J Med Genet 2008;45:22-8.
22. Guardiola M, Alvaro A, Vallvé J, et al. APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate. Nutr Metab Cardiovasc Dis 2012;22:756-62.
23. Sung J, Cho SI, Lee K, et al. Healthy Twin: A twin-family study of Korea-protocols and current status. Twin Res Hum Genet 2006;9:844-8.
24. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-5.
25. Lee SY, Park HS, Kim DJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72-80.
26. Caporaso JG, Lauber CL, Walters WA, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci USA 2011;108:4516-22.
27. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-Throughput community sequencing data. Nat Methods 2010;7:335-6.
28. Ramette A. Multivariate analyses in microbial ecology. FEMS Microbiol Ecol 2007;62:142-60.
29. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012;13:R79.
30. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60.
31. Sung J, Lee K, Song YM. Heritabilities of the metabolic syndrome phenotypes and related factors in Korean twins. J Clin Endocrinol Metab 2009;94:4946-52.
32. Lin HF, Boden-Albala B, Juo SH, et al. Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 2005;48:2006-12.
33. Almasy L, Blangero J. Multipoint quantitative-Trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-211.
34. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
35. Knights D, Silverberg MS, Weersma RK, et al. Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med 2014;6:107.
36. Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013;500:541-6.
37. Sanz Y, Olivares M, Moya-Pérez Á, et al. Understanding the role of gut microbiome in metabolic disease risk. Pediatr Res 2014;77:236-44.
38. Tagliabue A, Elli M. The role of gut microbiota in human obesity: recent findings and future perspectives. Nutr Metab Cardiovasc Dis 2013;23:160-8.
39. Wu X, Ma C, Han L, et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 2010;61:69-78.
40. Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010;5:e9085.
41. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009;106:2365-70.
42. Angelakis E, Armougom F, Million M, et al. The relationship between gut microbiota and weight gain in humans. Future Microbiol 2012;7:91-109.
43. Everard A, Belzer C, Geurts L, et al. Cross-Talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 2013;110:9066-71.
44. Armougom F, Henry M, Vialettes B, et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE 2009;4:e7125.
45. Million M, Maraninchi M, Henry M, et al. Obesity-Associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes 2011;36:817-25.
46. Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013;498:99-103.
47. Walter J. Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl Environ Microbiol 2008;74:4985-96.
48. Wang J, Tang H, Zhang C, et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 2015;9:1-15.
49. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222-7.
50. Schaap FG, Rensen PC, Voshol PJ, et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-Triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 2004;279:27941-7.
51. Zhang LS, Xu M, Yang Q, et al. Apolipoprotein AV deficiency enhances chylomicron production in lymph fistula mice. Am J Physiol Gastrointest Liver Physiol 2015;308: G634-42.
52. Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007;50:2374-83.
53. Russell DA, Ross RP, Fitzgerald GF, et al. Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol 2011;149:88-105.
54. Griffiths EA, Duffy LC, Schanbacher FL, et al. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 2004;49:579-89.
55. Haberman Y, Tickle TL, Dexheimer PJ, et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest 2014;124:3617.